ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market
Holding NDRA?
Track your performance easily

ENDRA Life Sciences (NDRA) Financial Statements

683 Followers

ENDRA Life Sciences Financial Overview

ENDRA Life Sciences's market cap is currently ―. The company's EPS TTM is $-44.13; its P/E ratio is >-0.01; ENDRA Life Sciences is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-1.78. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.23M$ -2.79M$ -3.10M$ -2.56M$ -2.94M
EBITDA$ -2.18M$ -2.73M$ -3.03M$ -2.48M$ -2.87M
Net Income Common Stockholders$ -2.23M$ -2.78M$ -3.10M$ -2.56M$ -2.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 4.82M$ 2.36M
Total Assets$ 10.44M$ 5.06M$ 7.60M$ 9.24M$ 6.65M
Total Debt$ 281.15K$ 324.06K$ 434.26K$ 472.65K$ 481.62K
Net Debt$ 281.15K$ 324.06K$ 434.26K$ -4.35M$ -1.87M
Total Liabilities$ 1.45M$ 1.36M$ 2.41M$ 2.31M$ 2.16M
Stockholders Equity$ 8.99M$ 3.70M$ 5.20M$ 6.93M$ 4.50M
Cash Flow-
Free Cash Flow$ -2.07M$ -2.17M$ -2.60M$ -2.27M$ -2.53M
Operating Cash Flow$ -2.08M$ -2.14M$ -2.60M$ -2.27M$ -2.51M
Investing Cash Flow$ 11.00K$ -23.80K--$ -27.00K
Financing Cash Flow$ 7.34M$ 468.90K$ 1.11M$ 4.73M-
Currency in USD

ENDRA Life Sciences Earnings and Revenue History

ENDRA Life Sciences Debt to Assets

ENDRA Life Sciences Cash Flow

ENDRA Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis